ADMA Biologics Long Term Deferred Assets (Quarterly) Trends

ADMA Biologics, Inc. (ADMA)

17.31 -0.19 (-1.09%) USD | NASDAQ | Jan 16, 16:00

17.22 -0.09 (-0.52%) After-Hours: 07:33

View Long Term Deferred Assets (Quarterly) for ADMA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Arcutis Biotherapeutics, Inc.	--
Vanda Pharmaceuticals, Inc.	Upgrade
Aldeyra Therapeutics, Inc.	Upgrade
Marker Therapeutics, Inc.	--
CorMedix, Inc.	--